| | | | | |
INBX Inhibrx Biosciences, Inc. Common Stock | $97,7750 | +3,33% | $1,44B | $165,95K | |
TMP Tompkins Financial Corporation | $98,5700 | -1,68% | $1,44B | $28,97K | |
BRUN Boost Run Inc. Class A Common Stock | $18,8390 | -6,41% | $1,44B | $2,07M | |
TWFG TWFG, Inc. Common Stock | $27,2650 | +1,81% | $1,44B | $79,95K | |
PCT PureCycle Technologies, Inc. Common stock | $7,1850 | +4,43% | $1,44B | $1,57M | |
REX REX American Resources Corp. | $44,0450 | -0,17% | $1,43B | $36,45K | |
NNNN Anbio Biotechnology Class A Ordinary Shares | $7,9400 | -4,91% | $1,43B | $36,81K | |
BTT BlackRock Municipal 2030 Target Term Trust | $22,6250 | +0,16% | $1,43B | $16,43K | |
ADNT Adient plc Ordinary Shares | $19,8400 | +1,85% | $1,43B | $169,99K | |
KALV KalVista Pharmaceuticals, Inc. Common Stock | $26,9900 | -0,04% | $1,43B | $1,83M | |
| $37,6090 | +0,13% | $1,43B | $506,38K | |
EMAT Evolution Metals & Technologies Corp. Common Stock | $2,8750 | -7,85% | $1,43B | $423,05K | |
DAO Youdao, Inc. American Depositary Shares, each representing one Class A Ordinary Share | $16,8350 | -1,03% | $1,42B | $66,99K | |
REPL Replimune Group, Inc. | $15,0100 | -3,66% | $1,42B | $1,99M | |
HCSG Healthcare Services Group | $23,0400 | +5,01% | $1,42B | $297,98K | |
